The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alternating application of gemcitabine/nab-paclitaxel (Gem/nab-Pac) and Gem monotherapy or continuous application of Gem/nab-Pac after induction treatment for first-line treatment of metastatic pancreatic cancer (mPC): First results from the randomized phase 2 ALPACA study from the German AIO study group (AIO-PAK-0114).
 
Klara Dorman
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; SERVIER
 
Stefan Hubert Boeck
Honoraria - MSD; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Incyte; Janssen-Cilag; MSD; SERVIER
 
Karel Caca
Consulting or Advisory Role - Oresco
Speakers' Bureau - Olympus; Oresco
Research Funding - Oresco
Travel, Accommodations, Expenses - Oresco
 
Maximilian Reichert
Honoraria - Falk Pharma; Roche; SERVIER
Speakers' Bureau - Falk Pharma; Roche; SERVIER
Patents, Royalties, Other Intellectual Property - EP18783030.2-1109; EP20206259.2
 
Thomas Jens Ettrich
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Incyte; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen
 
Helmut Oettle
No Relationships to Disclose
 
Oliver Waidmann
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Merck; MSD; Novartis; Roche; SERVIER
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; MSD; Novartis; Roche; Zentiva
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck; Roche
 
Dominik Paul Modest
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Sanofi; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Cor2Ed; Incyte; IQvia; Lilly; Merck Serono; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Roche; SERVIER
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Lothar Müller
No Relationships to Disclose
 
Patrick Michl
Speakers' Bureau - Amgen; Falk Pharma; MCI Healthcare; MSD; Roche
Travel, Accommodations, Expenses - Amgen; Galapagos NV
 
Stephan Kanzler
No Relationships to Disclose
 
Daniel Pink
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Deciphera (Inst); PharmaMar (Inst)
Speakers' Bureau - PharmaMar (Inst)
Research Funding - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst); PharmaMar (Inst); Roche (Inst)
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Janssen-Cilag; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Pierre Fabre; Roche
 
Michael Geißler
Honoraria - Amgen
 
Henning Pelz
Employment - PicnicHealth
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Amgen; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ingress Health; Janssen-Cilag; MSD; Novartis; Pfizer; Roche; Rönsberg; Takeda; Uniklinik Freiburg
Travel, Accommodations, Expenses - Abbvie; Alexion Pharmaceuticals; Amgen; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ingress; Janssen; MSD; Novartis; Pfizer; Roche; Rönsberg; Takeda
 
Volker Kunzmann
Honoraria - BMS GmbH & Co. KG
 
Swantje Held
No Relationships to Disclose
 
Thomas Schichtl
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Roche
 
Volker Heinemann
Honoraria - Amgen; AstraZeneca; Merck; MSD; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; Nordic Bioscience; Novartis; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; TERUMO
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merck
 
Frank Kullmann
Consulting or Advisory Role - Bayer; Novartis
Research Funding - Celgene